Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Authors of a new study stress the need to improve access to cancer screenings, especially for minorities and lower-income populations.
New diagnoses of bladder, colorectal, lung and prostate cancer fell during the spring of 2020 and did not return to previous levels.
But results from the Mass General Brigham system also found that racial and economic disparities remain for some tests.
National LGBT Cancer Network releases largest-ever survey of LGBTQIA+ cancer survivors.
The early cancer is detected, the easier it is to treat.
Studies have shown an alarming drop in screenings—and more advanced cancer—during the COVID-19 pandemic.
What would be the consequences of people missing their health and cancer screenings in 2020 due to COVID?
New report highlights cancer’s toll on racial and ethnic minorities and other underserved populations.
Data from a large COVID-19 and cancer registry also showed that hydroxychloroquine plus azithromycin is associated with higher mortality.
Those with blood cancers or lung cancer fared poorly in the first U.S. study of the new coronavirus n people with cancer.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.